Effect of Dapagliflozin as an Add-on Therapy to Insulin on the Glycemic Variability in Subjects with Type 2 Diabetes Mellitus (DIVE): A Multicenter, Placebo-Controlled, Double-Blind, Randomized Study

BACKGROUND: Glycemic variability is associated with the development of diabetic complications and hypoglycemia. However, the effect of sodium-glucose transporter 2 (SGLT2) inhibitors on glycemic variability is controversial. We aimed to examine the effect of dapagliflozin as an add-on therapy to ins...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Metab J
Main Authors: Lee, Seung-Hwan, Min, Kyung-Wan, Lee, Byung-Wan, Jeong, In-Kyung, Yoo, Soon-Jib, Kwon, Hyuk-Sang, Choi, Yoon-Hee, Yoon, Kun-Ho
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Diabetes Association 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8164951/
https://ncbi.nlm.nih.gov/pubmed/32602273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2019.0203
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados